Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia by Mullighan Charles G, Su Xiaoping, Zhang Jinghui, Radtke Ina, Phillips Letha A A, Miller Christopher B, Ma Jing, Liu Wei, Cheng Cheng, Schulman Brenda A, Harvey Richard C, Chen I-Ming, Clifford Robert J, Carroll William L, Reaman Gregory, Bowman W Paul, Devidas Meenakshi, Gerhard Daniela S, Yang Wenjian, Relling Mary V, Shurtleff Sheila A, Campana Dario, Borowitz Michael J, Pui Ching-Hon, Smith Malcolm, Hunger Stephen P, Willman Cheryl L, Downing James R, Children's Oncology Group in The New England journal of medicine (2009).

[PMID: 19129520] PubMed


Despite best current therapy, up to 20% of pediatric patients with acute lymphoblastic leukemia (ALL) have a relapse. Recent genomewide analyses have identified a high frequency of DNA copy-number abnormalities in ALL, but the prognostic implications of these abnormalities have not been defined.

[ hide abstract ]

Discussed In Paper


Dosing Information

No dosing information annotated.